The main causative gene is the bone morphogenetic protein receptor type 2 (BMPR2), which was first described as disease-causing for PAH in the year 2000 [4,5] and is part of the transforming growth factor beta (TGF-β) super family. Here, TGFB1 is linked to pulmonary arterial hypertension.